Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventive Approach to Congenital Heart Block With Hydroxychloroquine

NCT01379573 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01379573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01379573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventive Approach to Congenital Heart Block With Hydroxychloroquine
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2011
Completion date
July 16, 2020
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoantibody-associated heart block, congenital heart block, neonatal lupus